Bionime GmbH

Info

With our „peace of mind“ medical devices we offer solutions to patients to accurately manage and control their own health.

Geschichte

BIONIME is specialized in the business of biotechnology and medical testing. The first product line is the Self Monitoring Blood Glucose (SMBG) System. BIONIME integrates the top-tier expertise in medical science, chemistry, electronics and precision mechanism to commercialize the patented technology of unique test strip structure.
Today, BIONIME employs more than 500 employees and operates 3 subsidiaries in major markets, Europe, America and Asia. Our products have been highly recognized by outstanding clinical tests and well-known journals internationally and successfully distributed into the worldwide markets. With the support from our customers, we are confident to grow BIONIME the global competitive leadership in the field of SMBG.

"Bionime was established in April 2003 with the goal of improving the lives of people with diabetes through better self-monitoring. Bionime is focused on designing and manufacturing accurate medical testing equipment. Our first product line started out with accurate blood glucose monitors that mimic the capabilities state-of-the-art devices usually found in healthcare research facilities. Our product line has since expanded into multiple different Self-Monitoring Blood Glucose SMBG Systems.With the integration of top-tier scientific expertise, Bionime has successfully commercialized many patented technologies. This includes our unique Validus technology test strips which enables patients to receive accurate readings on-the-go."